Drug main Cipla on Friday mentioned its consolidated web revenue elevated 12 per cent to Rs 797 crore for the second quarter ended September 30.
The Mumbai-based drug maker had reported a consolidated web revenue of Rs 709 crore within the July-September interval of the earlier fiscal.
Its whole income from operations rose to Rs 5,829 crore for the September quarter from Rs 5,520 crore within the year-ago interval, Cipla mentioned in a regulatory submitting.
In respect of the switch of India-based US enterprise enterprise, the board determined to not proceed with the proposed switch, contemplating varied components, together with the present working surroundings, it added.
Shares of the corporate had been buying and selling 0.5 per cent up at Rs 1,154.10 apiece on the BSE.
(Solely the headline and movie of this report might have been reworked by the Enterprise Customary workers; the remainder of the content material is auto-generated from a syndicated feed.)
